Dow Up0.04% Nasdaq Up0.01%

Fate Therapeutics, Inc. (FATE)

-NGM
5.22 Down 0.13(2.39%) Aug 26 - Nasdaq Real Time Price
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income (20,894) (14,239) (13,427)
Operating Activities, Cash Flows Provided By or Used In
Depreciation965  674  695  
Adjustments To Net Income4,249  291  244  
Changes In Accounts Receivables -   -   -  
Changes In Liabilities1,578  405  134  
Changes In Inventories -   -   -  
Changes In Other Operating Activities(1,271)(405)209  
Total Cash Flow From Operating Activities (15,373) (13,274) (12,145)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(244)(709)(2)
Investments -   -   -  
Other Cash flows from Investing Activities6   -  202  
Total Cash Flows From Investing Activities (238) (709) 200  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock40,503  16,933  3,507  
Net Borrowings20,057  (250)3,600  
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 60,560   16,683   7,107  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents 44,949   2,700   (4,838)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.